Quoin Pharmaceuticals, Ltd. CEO Michael Myers' 2023 pay falls 36% to $1.3M
Quoin Pharmaceuticals, Ltd. reports 2023 executive compensation
By ExecPay News
Published: October 24, 2024
Quoin Pharmaceuticals, Ltd. reported fiscal year 2023 executive compensation information on October 24, 2024.
In 2023, three executives at Quoin Pharmaceuticals, Ltd. received on average a compensation package of $1M, a 41% decrease compared to previous year.
Average pay of disclosed executives at Quoin Pharmaceuticals, Ltd.
Michael Myers, Chief Executive Officer, received $1.3M in total, which decreased by 36% compared to 2022. 48% of Myers' compensation, or $602K, was in salary. Myers also received $301K in bonus, $292K in option awards, as well as $60K in other compensation.
Denise Carter, Chief Operating Officer, received a compensation package of $1.1M, which decreased by 41% compared to previous year. 45% of the compensation package, or $482K, was in salary.
Gordon Dunn, Chief Financial Officer, earned $776K in 2023, a 46% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on October 24, 2024.